Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Med (New York, N.Y.)
|
November 11, 2023
Selinexor: Changing the paradigm in patients with TP53 wild-type endometrial cancer?
Mohamed A Gouda, Kyaw Z Thein
Cancer Discovery
|
September 4, 2021
Tissue-Agnostic Drug Development: A New Path to Drug Approval
Kyaw Z Thein, Steven J Lemery, Shivaani Kummar
Ejhaem
|
July 18, 2022
Acalabrutinib-related second primary malignancies and nonmelanoma skin cancers in patients with chronic lymphocytic leukaemia (CLL): A systematic review and meta-analysis of randomised controlled trials (RCTs)
Thura W Htut, Myat M Han, Kyaw Z Thein
Cancers
|
October 16, 2024
Tissue-Agnostic Targeting of Neurotrophic Tyrosine Receptor Kinase Fusions: Current Approvals and Future Directions
Mohamed A Gouda, Kyaw Z Thein, David S Hong
Annual Review of Medicine
|
November 3, 2020
Therapeutics Targeting Mutant KRAS
Kyaw Z Thein, Amadeo B Biter, David S Hong
Journal of Community Hospital Internal Medicine Perspectives
|
January 27, 2025
Hyperhomocysteinemia-associated Thrombosis in Patients With Pernicious Anemia
Thura W Htut, Kyaw Z Thein, Thein H Oo
Journal of Geriatric Oncology
|
January 23, 2019
Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials
Somedeb Ball, Anita Sultan, Myo H Zaw, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 15, 2019
Case report of two siblings with type 2A von Willebrand disease involving a novel mutation within the calcium-binding site of the A2 domain of von Willebrand factor
Henry P Igid, Kyaw Z Thein, Michael Castine, et al.
Ejhaem
|
July 18, 2022
Efficacy of daratumumab combination regimen in patients with multiple myeloma: A combined analysis of phase III randomized controlled trials
Thura W Htut, Kyaw Z Thein, Alastair Lawrie, et al.
Cancers
|
July 27, 2024
Target-Driven Tissue-Agnostic Drug Approvals-A New Path of Drug Development
Kyaw Z Thein, Yin M Myat, Byung S Park, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Med (New York, N.Y.)
|
November 11, 2023
Selinexor: Changing the paradigm in patients with TP53 wild-type endometrial cancer?
Mohamed A Gouda, Kyaw Z Thein
Cancer Discovery
|
September 4, 2021
Tissue-Agnostic Drug Development: A New Path to Drug Approval
Kyaw Z Thein, Steven J Lemery, Shivaani Kummar
Ejhaem
|
July 18, 2022
Acalabrutinib-related second primary malignancies and nonmelanoma skin cancers in patients with chronic lymphocytic leukaemia (CLL): A systematic review and meta-analysis of randomised controlled trials (RCTs)
Thura W Htut, Myat M Han, Kyaw Z Thein
Cancers
|
October 16, 2024
Tissue-Agnostic Targeting of Neurotrophic Tyrosine Receptor Kinase Fusions: Current Approvals and Future Directions
Mohamed A Gouda, Kyaw Z Thein, David S Hong
Annual Review of Medicine
|
November 3, 2020
Therapeutics Targeting Mutant KRAS
Kyaw Z Thein, Amadeo B Biter, David S Hong
Journal of Community Hospital Internal Medicine Perspectives
|
January 27, 2025
Hyperhomocysteinemia-associated Thrombosis in Patients With Pernicious Anemia
Thura W Htut, Kyaw Z Thein, Thein H Oo
Journal of Geriatric Oncology
|
January 23, 2019
Secondary hematologic malignancies with poly adenosine diphosphate ribose polymerase inhibitors: Is the buzz real? -Insights from a meta-analysis of phase 3 randomized controlled trials
Somedeb Ball, Anita Sultan, Myo H Zaw, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 15, 2019
Case report of two siblings with type 2A von Willebrand disease involving a novel mutation within the calcium-binding site of the A2 domain of von Willebrand factor
Henry P Igid, Kyaw Z Thein, Michael Castine, et al.
Ejhaem
|
July 18, 2022
Efficacy of daratumumab combination regimen in patients with multiple myeloma: A combined analysis of phase III randomized controlled trials
Thura W Htut, Kyaw Z Thein, Alastair Lawrie, et al.
Cancers
|
July 27, 2024
Target-Driven Tissue-Agnostic Drug Approvals-A New Path of Drug Development
Kyaw Z Thein, Yin M Myat, Byung S Park, et al.
Page
of 3